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Summary
We describe a family with severe progressive cerebellar
ataxia involving the trunk, the extremities, and speech.
The proband, who has prominent atrophy of the
cerebellum, shown by magnetic resonance imaging,
was confined to a wheelchair at the age of 44 years.
Two sons have episodes of vertigo and ataxia that are
not responsive to acetazolamide. Quantitative eye-
movement testing showed a consistent pattern of
abnormalities localizing to the cerebellum. Genotyping
suggested linkage to chromosome 19p, and SSCP
showed an aberrant migrating fragment in exon 6 of the
calcium-channel gene CACNA1A, which cosegregated
with the disease. Sequencing of exon 6 identified a GrA
transposition in one allele, at nucleotide 1152, resulting
in a predicted glycine-to-arginine substitution at codon
293. The CAG-repeat expansion associated with
spinocerebellar ataxia 6 was not present in any family
members. This family is unique in having a non–CAG-
repeat mutation that leads to severe progressive ataxia.
Since a great deal is known about the function of calcium
channels, we speculate on how this missense mutation
leads to the combination of clinical symptoms and signs.
Introduction
The number of abnormal genes associated with inherited
cerebellar-ataxia syndromes is increasing rapidly; yet,
there is still relatively little known about how different
mutations lead to specific phenotypes (Junck and Fink
1996). There has been a surprisingly large clinical het-
erogeneity both within families with the same mutation
and across families with mutations in the same gene
(Higgins et al. 1996). A further complication is that most
of the identified genes code for proteins for which nor-
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mal function is poorly understood. When genotype-phe-
notype correlation is considered, one of the most inter-
esting genes is the calcium-channel gene CACNA1A
(previously called “CACNL1A4”), which codes for the
main transmembrane component of a calcium channel
expressed throughout the brain but expressed particu-
larly heavily in the cerebellum (Mori et al. 1991; Volsen
et al. 1995; Ludwig et al. 1997). Recently, Ophoff et al.
(1996) reported four different missense mutations in
conserved functional domains in four families with fa-
milial hemiplegic migraine (FHM) and two mutations
disrupting the reading frame in two families with epi-
sodic ataxia type 2 (EA-2). Both of these disorders can
have a mildly progressive interictal ataxia, particularly
with EA-2, but patients are not affected severely and
neither disorder shortens the expected life span. At al-
most the same time as Ophoff et al. (1996), Zhuchenko
et al. (1997) reported that expansion of a CAG-repeat
segment in CACNA1A (which normally has 4–16 re-
peats) to 21–27 repeats caused a moderately progressive
cerebellar-ataxia syndrome that typically begins when
patients are in their 30s–40s. They named this autosomal
dominant syndrome “spinocerebellar ataxia 6” (“SCA-
6”). However, unlike the other spinocerebellar-ataxia
syndromes caused by expanded CAG repeats, the ex-
panded repeats with SCA-6 were stable. There was no
evidence of anticipation from generation to generation.
We now report another clinical phenotype due to a
missense mutation in the highly conserved pore region
of CACNA1A. Some patients in this family exhibited a
severe progressive cerebellar-ataxia syndrome without
episodic features, whereas others had a combination of
episodic ataxia and progressive ataxia. Since a great deal
already is known about the function of calcium channels
and their distribution within the nervous system, the
range of mutations in CACNA1A provides a unique
model with which to begin the process of explaining
clinical symptoms and signs, on the basis of specific
mutations.
Subjects and Methods
Proband
Starting at the age of 15 years, the proband noted the
gradual onset of imbalance and incoordination. The
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Figure 1 MRI of the cortex and cerebellum of the proband
(II-6). The sagittal section through the vermis shows prominent at-
rophy. T1 is weighted.
symptoms gradually progressed, and she first noted slur-
ring of speech in her 20s. In her early 40s, her gait
deteriorated more rapidly, and she experienced several
falls, forcing her to use a walker. At the age of 44 years,
she became confined to a wheelchair and has remained
so for the past 10 years. She denied ever having any
episodes of imbalance or vertigo and never experienced
migraine headaches. When first seen at UCLA, at the
age of 54 years, she could stand with a markedly wid-
ened base but could not take even a single step without
support. She could not stand with her feet together, even
with her eyes open. She exhibited a horizontal gaze-
evoked nystagmus of equal amplitude to the right and
to the left, with rebound nystagmus in the primary po-
sition after returning from either side. There wasmarked
dysrhythmia and dysmetria in the upper extremities,
with bilateral intention tremor (left greater than right).
No brain-stem or spinal-cord signs were identified.Mag-
netic resonance imaging (MRI) showed prominent cer-
ebellar atrophy with lesser diffuse cortical atrophy (fig.
1). The brain stem was normal.
Affected Family Members
The proband (II-6; fig. 2A) reported that her mother
(I-2) had experienced a similar gradually progressive
ataxia syndrome beginning before the age of 20 years
and progressing to profound ataxia in her late 40s. She
died in her early 60s of unknown cause. Two maternal
aunts and a maternal uncle had exhibited a similar pro-
gressive ataxia syndrome, all dying in their 60s of un-
known causes. The proband did not know of any epi-
sodic features in her mother, aunts, or uncle. The
proband had seven children by four different husbands.
Three of the children, each from a different father, ex-
hibit an ataxia syndrome. At the age of ∼15 years, her
34-year-old son (III-4) began having dizzy spells lasting
several hours, characterized by vertigo, nausea, and
vomiting, with ataxia and slurring of speech. These spells
occurred as frequently as two or three times per month,
but he then could go as long as 6 mo without a spell.
Between the spells, there was a gradual deterioration in
balance, with incoordination of the extremities and slur-
ring of speech, that has progressed gradually over the
past 20 years. The proband’s 31-year-old daughter
(III-6) has noted a gradually progressive ataxia syn-
drome, beginning at the age of ∼10 years and progress-
ing over the years to involve the coordination of her
upper extremities and the development of slurred speech.
She has never experienced any episodes of vertigo or
ataxia but does have episodic headaches that meet the
International Headache Society (IHS) criteria for mi-
graine without aura. Since the age of 5 years, another
son (III-3) has experienced severe recurrent attacks of
vertigo, nausea, and vomiting, with ataxia of the trunk
and extremities. These episodes last for as long as 1 d
and recently have been occurring two or three times per
week so that he is unable to work. With his recent at-
tacks, he has noted painful dysesthesias in his right hand
and right foot. Between attacks, he has had a slowly
progressive truncal and extremity ataxia, with slurring
of speech. He also has headaches that meet the IHS
criteria for migraine without aura. On examination, all
three of the proband’s affected children exhibited truncal
ataxia, ataxia of the upper extremities, and slurring of
speech. They also each had horizontal gaze-evoked nys-
tagmus, with rebound nystagmus in the primary posi-
tion. None exhibited brain-stem or spinal-cord signs.
Neither son with episodic ataxia responded to treatment
with acetazolamide. The study was approved by our
institutional review board, and appropriate informed
consent was obtained from all subjects.
Eye-Movement Recordings
Eye movements were recorded with direct-current
electro-oculography. Detailed descriptions of the record-
ing system, data analysis, and normative data have been
reported elsewhere (Baloh et al. 1980; Moschner et al.
1994). With the subject seated and the head fixed by a
brace, saccades were generated by a laser target moving
in a square wave pattern of pseudorandom frequency,
direction, and amplitude. Smooth pursuit was generated
with the same laser target moving in a sinusoidal pattern
(0.2 and 0.4 Hz; peak velocities of 23/s and 45/s, re-
spectively). Optokinetic nystagmus (OKN) was induced
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Figure 2 A, Pedigree of family with progressive ataxia. Blackened symbols indicate affected individuals. B, Results of SSCP analysis of
exon 6, showing aberrantly migrating fragments in affected family members but not in unaffected family members or in normal controls (lanes
wt1 and wt2). C, Sequence of exon 6 (top), showing a GrA transposition in one allele (indicated by the arrows), at nucleotide 1152, in affected
family members, and ASOs (bottom), showing that the mutant oligonucleotide detected the mutant allele in affected but not in unaffected
individuals. The normal (wild-type) allele detected all individuals.
with the subject seated inside a cloth drum 1 m in di-
ameter. The drum was made of black cloth with 3-wide
vertical stripes spaced at intervals of l5.6. The drum
was rotated at a constant velocity of 30/s clockwise and
counterclockwise as well as sinusoidally (0.05 Hz; peak
velocity of 60/s). The vestibulo-ocular reflex (VOR)was
tested by sinusoidal rotations (0.05 Hz; peak velocity of
60/s), with the subject’s eyes open in darkness. Fixation
suppression of the VOR (VOR-F) was tested by sinu-
soidally rotating (0.05 Hz; peak velocity of 60/s) the
subject in the dark, with a small fixation light attached
to the chair, directly in front of the subject.
Genotyping
Genomic DNA from each individual was extracted
from peripheral blood, with a DNA-extraction kit (Gen-
tra system). Microsatellite markers on chromosome l9p
were typed by use of the standard PCR protocol, except
that [a-32P]-dCTP (ICN Biomedicals) was used (Vignal
et al. 1993). PCR products were resolved on 6% de-
naturing polyacrylamide gels. Pedigree allelotypes were
inferred after autoradiography. The markers used for
this study were D19S413, D19S865, D19S914,
D19S221, D19S226, D19S841, and D19S253 and are
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listed in order, from distal to proximal on 19p (Dib et
al. 1996; Ducros et al. 1996).
SSCP Analysis
PCR products of exons in CACNA1A were screened
for molecular variants, by SSCP analysis (Orita et al.
1989; Ravnik-Glavac et al. 1994). The published prim-
ers (Ophoff et al. 1996) were used to amplify all 47
exons from the introns flanking each exon, except for
exons 37 and 43, for which the primers had to be
redesigned. The sequences of the redesigned primers are
as follows: 37F, 5′-CGTGTGAACCCATTGCCTGCA-
3′; 37R, 5′-CCCAAGCCACACTCATTCCA-3′; 43F,
5′-TTGTGATCTGGAGGTCAGGCCC-3′; and 43R,
5′-AGTGCAGAGTGAGGGGTCCAGC-3′. PCR was
performed under conditions optimized for each individ-
ual primer pair. All 47 exons were amplified in patients
II-6 and III-3 and in 15 normal controls, and exon 6
was amplified in the entire subject family. Products were
labeled by inclusion of [a-32P]-dCTP in the PCR. PCR
products then were denatured and loaded onto 0.5#
mutation-detection enhancement gels (AT Biochem) and
were electrophoresed at 4C, with or without 10% glyc-
erol. After autoradiography of the gels, conformers were
identified by visual inspection.
DNA Sequence Analysis
Exon 6 was PCR amplified for each member of this
family. PCR products were separated by electrophoresis
on 1.5% low-melting agarose gels. Single bands were
excised from the gel and were treated with the GENE-
CLEAN kit (BIO 101). The sequences of the purified
DNA samples were generated by the Thermo Sequenase
cycle-sequencing kit (Amersham), by use of the manu-
facturer’s recommended conditions. Nucleotide and
exon numbering of CACNA1A are according to
GenBank accession numbers X99897 and Z80119 (http:
//www.ncbi.nlm.nih.gov/).
Allele-Specific Hybridization
To analyze more unaffected individuals, allele-specific
oligonucleotides (ASOs) were developed, and exon 6
was amplified as described, for family members and for
88 normal controls, in a 96-well plate (Thermowell;
Corning Costar). The PCR conditions consisted of 5 min
of 95C denaturation followed by 35 cycles of 45 s at
94C, 35 s at 55C, and 1 min at 72C and by a final
elongation step of 7 min at 72C. PCR products then
were transferred onto the Hybond N membranes, by
a 96-pin replicator (V & P Scientific). After denaturation
in 0.4 M NaOH and neutralization in 2# SSC, the air-
dried filters were prehybridized in ExpressHyb solution
(Clontech Laboratories) for 30 min at 37C and then
were hybridized for 1 h at 37C, with either the wild-
type ASO with the sequence 5′-ACTGGGAAGGGC-
CCAAC-3′ or the mutated ASO 5′-ACTGGGAAAGGC-
CCAAC-3′. Oligonucleotides were end-labeled by use of
T4 polynucleotide kinase (New England Biolabs) and
[g-32P]-ATP. Filters were washed in 2# SSC and 0.5%
SDS for 30 min at 37C, followed by a wash in 0.2#
SSC and 0.5% SDS for 20 min at 52C, and then were
exposed to film.
(CAG)n-Repeat Analysis
Determination of the number of CAG repeats in
CACNA1A has been described elsewhere (Zhuchenko
et al. 1997). In brief, PCR products were electrophoresed
in denaturing polyacrylamide gels and were compared
with a sequencing ladder. Homozygous alleles were se-
quenced, to confirm the number of CAG repeats.
Results
Clinical Data
The age at onset of ataxia varied within the range of
5–15 years. In both of the proband’s affected sons, ep-
isodes were triggered by emotional upset and physical
exertion. Two of four reported headaches met the IHS
criteria for migraine without aura. A uniform pattern of
eye-movement abnormalities was found in all affected
individuals (table 1). All affected individuals had gaze-
evoked and rebound nystagmus, and all had profound
impairment of smooth pursuit, OKN, and fixation sup-
pression of vestibular nystagmus. Saccades and VOR
responses were consistently normal.
Haplotype Analysis
Microsatellite-marker typing at chromosome l9pl3
confirmed that, from marker D19S914 to marker
D19S841, all three affected children shared the same
haplotype with their affected mother. Recombination
was observed between D19S865 and D19S914 on the
telomeric side and between D19S841 and D19S253 on
the centromeric side, defining an interval of∼9 cM. Link-
age analysis was not feasible, because of the size of this
family; however, the allelic segregation from this family
suggested a possible genomic colocalization with EA-2/
FHM (Baloh et al. 1997).
Mutation Detection
All 47 exons and flanking introns were subjected to
SSCP analysis of PCR-amplified genomic DNA. The af-
fected individuals showed aberrantly migrating frag-
ments in exon 6, which were not observed in unaffected
individuals from the same family or in controls (fig. 2B).
Sequencing of exon 6, for each affected individualwithin
this family, revealed a GrA transposition in one allele,
at nucleotide 1152 of the CACNA1A open reading
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Table 1
Results of Quantitative Oculomotor Testing of Four Patients with a Mutation in
CACNA1A
PATIENT
SACCADES
PURSUITd OKNe VORf VOR-Fg
Velocitya
(/s) Accuracyb
Delayc
(ms)
II-6 375 86 185 .21 .16 .34 .31
III-3 300 75 190 .15 .09 .55 .40
III-4 350 75 181 .07 .10 .39 .25
III-6 325 73 168 .40 .11 .33 .15
a Average peak velocity of 20 saccades; minimum of 10 saccades. Normal 1280/s.
b Target displacement/eye displacement #100; average of 40 saccades. Normal 75–100.
c Between target displacement and saccade initiation; average of 40 saccades. Normal
!230 ms.
d Gain  peak eye velocity/peak target velocity, 0.4 Hz, 45/s. Normal 1.58.
e Gain  peak slow-phase eye velocity/peak stimulus velocity, 0.05 Hz, 60/s. Normal
1.50.
f Gain  peak slow-phase eye velocity/peak stimulus velocity, 0.05 Hz, 60/s. Normal
1.30.
g Gain  peak slow-phase eye velocity/peak stimulus velocity, 0.05 Hz, 60/s. Normal
!.13.
frame (fig. 2C). This alteration predicts a substitution of
glycine by arginine, at codon 293. In the controls, we
also identified two new polymorphisms, in exon 4
(g854a) and in exon 46 (t6938c), that have not been
reported previously. ASO hybridization analysis showed
that the mutant oligonucleotide detected the mutant al-
lele in affected individuals but not in unaffected indi-
viduals in the family (fig. 2C). Furthermore, no hybrid-
ization was detected among 88 DNA samples from
normal controls. In contrast, there were strong signals
when the normal oligonucleotide was used as a hybrid-
ization probe for all samples. We therefore confirmed
the complete segregation of this mutation with the dis-
ease phenotype.
CAG Expansion
Because of the phenotypic overlap between the family
in this study and SCA-6 patients, the CAG-repeat length
at the 3′ end of CACNA1A was determined. There were
two alleles in our patients; one had 11 CAG repeats
(mutant allele), and the other had 13 CAG repeats (the
normal range is 4–16 CAG repeats). The haplotypes in
the patients were as follows: for II-6, 11/13; for III-3,
11/13; for III-4, 11/11; and, for III-6, 11/13.
Discussion
Clinical Features
Although this family has clinical features in common
with other reported families with mutations in
CACNA1A (Ophoff et al. 1996; Zhuchenko et al. 1997),
there also were several unique features. The proband,
her mother, and her daughter exhibited a relentlessly
progressive cerebellar-ataxia syndrome, with clinical
signs suggesting involvement of the cerebellar vermis and
the hemispheres. This is the first report of a missense
mutation resulting in such a severe progressive ataxia
syndrome. The clinical course is similar to that of fam-
ilies reported to have CAG-repeat syndromes, such as
SCA-1, SCA-2, and SCA-3 (Junck and Fink 1996). How-
ever, unlike patients with these spinocerebellar-ataxia
syndromes, the members of the family in this study did
not exhibit any extracerebellar signs. Interestingly, the
proband’s two sons, each by a different father, had severe
episodes of vertigo and ataxia, with progressive interictal
ataxia. Unlike other patients with EA-2 (Baloh et al.
1997), however, neither of them responded to acetazo-
lamide. As with other patients with EA-2, both sons
noted that episodes of vertigo and ataxia could be pre-
cipitated by stress, emotional upset, and exercise. Finally,
for the two patients with progressive ataxia and for
the two patients with episodic and progressive ataxia,
quantitative measurement of interictal eye movements
showed the same overall pattern of abnormality reported
elsewhere for EA-2 patients (Baloh et al. 1997).
The generalized ataxia involving the limbs and trunk,
with slurring of speech, indicates diffuse cerebellar dys-
function in this family. The interictal oculomotor find-
ings of gaze-evoked and rebound nystagmus, along with
severe pursuit and optokinetic deficits, also are localizing
to the cerebellum. The profound deficit in visual tracking
and in visual-vestibular interaction is particularly char-
acteristic of lesions of the flocculonodular lobe (Baloh
et al. 1986). The normal saccade velocity, accuracy, and
latency measurements, along with normal VOR function
and the absence of any long-tract signs, determined by
neurological examination, indicate that the brain stem
was not involved. MRI confirmed severe cerebellar at-
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rophy with a normal-appearing brain stem. Although
CACNA1A is expressed in neurons throughout the
brain, it is expressed heavily in the cerebellum (Mori et
al. 1991). Hybridization with CACNA1A-specific ri-
boprobes in rat found heavy labeling of Purkinje neu-
rons, granule cells, and neurons in the molecular layer
(Ludwig et al. 1997).
Functional Implications of the Mutation in CACNA1A
The four homologous domains in the a1A calcium-
channel subunit each have six putative a-helical
membrane-spanning segments (S1–S6) (Catterall 1995).
The central pore is lined by four P regions (pore loops)
interconnecting putative membrane-spanning segments
S5 and S6 of each domain (fig. 3A). Calcium selectivity
is achieved by interaction between calcium ions and
high-affinity binding sites in the P regions. Studies using
mutagenesis to change specific amino acids in the pore
region have shown that the selectivity filter is formed by
the pore loops, which are relatively short polypeptide
segments that extend into the aqueous pore from one
side of the membrane (fig. 3B) (Heinemann et al. 1992;
Yang et al. 1993). A large portion of the pore loop is
near the extracellular face of the channel, and only a
small segment extends into the membrane, to produce
the selectivity filter. The loops extending into the pore
allow the ion channel to place the proper functional
groups at the correct positions in space, to achieve se-
lective ion binding. For example, with calcium channels,
glutamate residues from each of the four pore loops
determine the calcium selectivity (Heinemann et al.
1992). The calcium channel is believed to be composed
of the integral membrane subunits (S1–S6) arranged in
a ring, like the staves of a barrel, around a central pore
(MacKinnon 1995). The four pore loops reach into the
barrel and confer the ion-conduction properties. Chan-
nel gating arises from conformational changes in the
transmembrane barrel staves of the subunits.
The missense mutation causing the clinical syndrome
in this family resulted in a glycine-to-arginine change in
the putative P region in domain I (fig. 3A). Phylogenet-
ically, in all organisms, from the fly (Drosophila) to hu-
mans, glycine at codon 293 is a highly conserved amino
acid in all sequenced a1 units (fig. 3C) (Stea et al. 1995;
Peixoto et al. 1997). The mutation results in a major
change in this key pore region, since glycine is an un-
charged amino acid with a small side chain, whereas
arginine is a basic hydrophilic amino acid with a large,
positive side chain. Furthermore, position 293 is only a
few amino acids away from the key conserved glutamate
position, the central pore amino acid critical for the de-
termination of calcium selectivity (fig. 3C).
Comparison with Other CACNA1A Mutations
A range of phenotypes has been associated with dif-
ferent mutations in CACNA1A (table 2). Four different
missense mutations were found in families with hemi-
plegic migraine (Ophoff et al. 1996). All four point mu-
tations were in conserved functional domains, one, a
missense mutation resulting in a shift from threonine to
methionine at position 666, being in the pore region of
the S2 domain. The latter family had a mild interictal
ataxia in addition to episodes of hemiplegic migraine.
Two families with EA-2 were found to have mutations
that disrupted the reading frame in S1 and S2 of domain
3 and that, thus, were predicted to produce truncated
a1A subunits (Ophoff et al. 1996).We recently identified
a spontaneous mutation, in a patient with EA-2, that
resulted in a premature stop codon and a putative trun-
cated a1A subunit (authors’ unpublished data). Ex-
panded CAG repeats in the open reading frame of the
carboxyl terminus of CACNA1A result in a progressive
ataxia beginning later in life, usually after the age of 40
years (Zhuchenko et al. 1997). Some members of fam-
ilies with these expanded CAG repeats can have episodic
features, although these features are not as prominent
as those with EA-2. The ataxia with SCA-6 is more
progressive than that with hemiplegic migraine or with
EA-2, although it does not appear to shorten the life
span. The family in this study exhibited a severe pro-
gressive ataxia involving the trunk and the extremities,
with two members also having prominent episodes of
vertigo and ataxia. The early onset and the progression
to a condition requiring a wheelchair, in the 40s, is
unique.
How do mutations in the same gene lead to such var-
ied clinical syndromes? The location and type of mu-
tation are important but probably not the only deter-
mining factors. Features of the normal allele and features
of other similar and modifying genes could alter the
phenotypic expression. Environmental factors also may
be important. Migraine headaches, which occur with
hemiplegic migraine and EA-2 (Baloh et al. 1997) and
which occurred in the family reported here, may be a
nonspecific secondary phenomenon due to the under-
lying neuronal metabolic defect (Moskowitz 1990).
Comparison with Other Channelopathies
A range of human ion channelopathies has been de-
scribed elsewhere (Ptacek 1994). Most involve muscle,
presenting with episodic weakness or paralysis that usu-
ally is responsive to acetazolamide. Hypokalemic peri-
odic paralysis is caused by mutations in CACNA1S,
which codes for the a1S transmembrane subunit of the
skeletal muscle L-type voltage-gated calcium channel
(Ptacek et al. 1994). Mutations in the sodium-channel
gene SCN4A, resulting in hyperkalemic periodic paral-
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Figure 3 A, Schematic drawing of the a1A subunit of a calcium channel coded for by CACNA1A. Each of the four domains (I–IV) has
six transmembrane segments (1–6). The pore-forming regions (pore loops) are between segments 5 and 6. The blackened circle indicates the
location of the predicted glycine-to-arginine substitution in the family in this study. B, Illustration of how the central pore of the channel is
thought to be formed by pore loops from the four domains (left) and of how the pore might be distorted by the glycine-to-arginine substitution
in the pore loop of domain I (right) (domain III was removed, for clarity). C, Sequence of the pore region of domain I, in different a1 subunits,
showing conserved amino acids (Stea et al 1995; Peixoto et al. 1997). The arrow indicates the glycine (G)–to–arginine (R) substitution in the
family in this study. The boldface “E” indicates the position of the key central-pore glutamate.
ysis, are probably the best characterized, in terms of
phenotype-genotype correlation (Ptacek et al. 1991; Ro-
jas et al. 1991). Hyperkalemic periodic paralysis is an
autosomal dominant disorder in which elevations in se-
rum potassium concentration trigger attacks of muscle
weakness. During the attacks, the muscle fiber’s resting
potential is abnormally depolarized, thus making the
sarcolemma electrically inexcitable. Cannon (1996) ob-
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Table 2
Phenotypes Associated with Different Mutations in CACNA1A
Phenotype Mutation
Age at Onset
(years) Ataxia Course
Hemiplegic migraine/
basilar migraine
Missense 2–30 Stable, exam often normal
EA-2 Interrupts reading
frame
3–30 Mildly progressive
SCA-6 CAG repeats in open
reading frame
130 Moderately progressive
Episodic and
progressive ataxia
Missense 5–15 Severely progressive
served that, at the single-channel level, 5%–10% of mu-
tant sodium channels from biopsied muscle failed to in-
activate and that there was an increased open time and
open probability in the setting of high extracellular po-
tassium concentration. Impaired fast inactivation of this
seemingly small fraction of sodium channels was shown
to be empirically and theoretically sufficient to cause
muscle paralysis (Cannon and Corey 1993; Cannon and
Stritmatter 1993).
The only other human channelopathy involving neu-
rons is episodic ataxia type 1 (EA-1), resulting from
missense mutations in a brain potassium channel,
KCNA1 (Browne et al. 1994). Patients with EA-1 typ-
ically present in early childhood, with brief attacks of
ataxia lasting minutes and with interictal myokymia but
no interictal nystagmus or ataxia. So far, in families with
EA-1, six different missense mutations have been iden-
tified; these mutations result in changes in amino acids
in the transmembrane or the intracellular segments but
do not involve the pore region (Browne et al. 1994,
1995). Studies of the mutated channels expressed inXen-
opus oocytes suggested that the cellular mechanism un-
derlying EA-1 is an inability of neurons to repolarize
after an action potential, because of altered delayed rec-
tifier function (Adelman et al. 1995). The abnormal sub-
units affected potassium-channel function, either by for-
mation of homomeric channels with altered functions
or by coassembly with wild-type subunits.
Mutations in the mouse a1A voltage-gated calcium-
channel gene cause two recessively inherited neurolog-
ical disorders, “tottering” and “leaner.” Tottering mice
have motor seizures and slowly progressive ataxia, be-
ginning around the third postnatal week, whereas leaner
mice have absence spells (i.e., brief seizures) and are
severely ataxic, often not surviving past weaning. With
regard to tottering, a missense mutation results in a non-
conservative amino acid change near the second P do-
main, and, with regard to leaner, mutations of a splice
donor consensus result in expression of novel carboxy-
terminal sequences (Fletcher et al. 1996). The finding of
epileptic seizures in the mouse models raises the likely
possibility that even more phenotypes will be associated
with mutations in CACNA1A in humans.
Overview Hypothesis
A simple working hypothesis to explain the clinical
syndromes associated with mutations in ion channels is
that episodes are due to transient impairment of channel
activation and/or deactivation, whereas progressive in-
terictal signs are due to chronic excess entry of calcium
into the cell or release of intracellular calcium, leading
to abnormal activation of intracellular signals and ul-
timately to cell death (apoptosis). Bothmechanisms seem
to occur with most mutations, although some mutations
are relatively specific for episodic symptoms (e.g., some
families with hemiplegic migraine), whereas others pro-
duce progressive symptoms (e.g., families with SCA-6).
Studies of patients with hyperkalemic periodic paralysis
due to mutations in SCN4A suggest likely mechanisms
for these two different processes. Increased open time
and open probability of mutant channels, triggered by
high extracellular potassium, lead to depolarization of
the muscle cells and paralysis, whereas chronic abnormal
levels of intracellular calcium lead to activation of in-
tracellular messenger pathways that ultimately lead to
cell death. Patients with hyperkalemic periodic paralysis
typically develop muscle atrophy and weakness after
many years of episodic weakness. Assuming analogous
mechanisms with mutations in the calcium-channel gene
CACNA1A, episodes such as those seen with hemiplegic
migraine and EA-2 can be assumed to result from tran-
sient loss of function, leading to transient neuronal de-
polarization, primarily of cerebellar neurons. Chronic
progressive ataxia, such as that seen in SCA-6 patients
and in the family in this study, results from chronic ex-
cess entry of calcium into neurons and excess activation
of calcium’s intracellular signaling pathways, ultimately
leading to cell death (Koh and Cottman 1996; Rettig et
al. 1996). Although interrelated, these two different
pathophysiological mechanisms can be relatively inde-
pendent, even among family members with the same
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mutation. Two members of the family in this study had
prominent episodes of ataxia, whereas two others never
had episodes. All four, however, exhibited gradually pro-
gressive ataxia.
Calcium channels such as CACNA1A are exquisitely
sensitive to changes in the concentration of pH and of
potassium (Hille 1992). As noted above, a change in
potassium levels is presumably the mechanism for ace-
tazolamide responsiveness, in patients with hyperka-
lemic periodic paralysis. It has long been known that
changes in pH have a prominent effect onmost ion chan-
nels, but only recently has the mechanism of pH-de-
pendent control of channel function been studied at the
molecular level. A decreasing pH (increasing the number
of free protons) strongly inhibits ion permeation through
open calcium channels. Recently, it has been shown that
the protonation site in the L-type voltage-regulated cal-
cium channel lies within the pore (Chen et al. 1996). It
is formed by a combination of conserved pore-region
glutamates, the amino acids shown to be the key to
calcium selectivity of these channels (fig. 3C) (Heine-
mann et al. 1992). This mechanism is a simple molecular
explanation for the modulatory effect of H ions on
open-channel flux and for the competition between H
ions and divalent cations. By increasing the extracellular
proton concentration in the cerebellum (Bain et al.
1992), acetazolamide presumably stabilizes mutant
channels that fail to properly inactivate. Our patients
were not responsive to acetazolamide, possibly because
the missense mutation distorted the pore region, altering
the stabilizing effect of H ions.
It is interesting to consider how the missense mutation
in the pore regions found in this family led to the dif-
ferent clinical symptoms and signs. Replacement of a
neutral amino acid, glycine, with a positively charged
amino acid, arginine, near the center of the pore in do-
main I would be likely to lead to a distortion of the pore
region (fig. 3B). The fact that two patients with this
mutation had prominent episodes whereas the other two
patients had no episodes indicates that other factors,
such as other modifying genes or, possibly, metabolic
factors such as hormone levels, are important in the
determination of susceptibility to episodic dysfunction.
On the other hand, all four patients exhibited gradually
progressive ataxia, indicating that this pore mutation
resulted in chronic increased intracellular calcium, ul-
timately leading to neuronal death.
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